75 -6 (80) 2025 - G.S. Khodjieva - PECULIARITIES OF COMPLIANCE IN PATIENTS DURING IRON DEFICIENCY ANEMIA THERAPY

PECULIARITIES OF COMPLIANCE IN PATIENTS DURING IRON DEFICIENCY ANEMIA THERAPY

G.S. Khodjieva - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Purpose. To study the psychological aspects of adherence to treatment in patients with iron deficiency anemia. Material and methods. The research was carried out by means of questionnaires on the basis of large outpatient institutions in 4 regions. The age of the patients who took the questionnaire ranged from 18 to 60 years. A total of 2000 patients were examined, 500 patients in each area. The research was carried out on the basis of the Compliance Level questionnaire. Results. A high level of adherence was noted only in 59% of the respondents, while 3.6% had low adherence, and 37.3% - medium. The most pronounced was the decrease in the behavioral aspect, which manifests itself in the patient's inattention or frivolous attitude towards therapy. The proportion of patients with a low level of behavioral compliance was 42.8%. An average level of behavioral compliance was determined in 35.8% of patients, while the level was high in 21.4% of patients. Output. A high level of compliance was observed only in 59% of the patients with IDA surveyed. At the same time, patients with a low level of compliance showed a pronounced deficit of the behavioral component

Key words: iron deficiency anemia; commitment; compliance; questioning; psychological aspects

First page

369

Last page

373

For citation:G.S. Khodjieva - PECULIARITIES OF COMPLIANCE IN PATIENTS DURING IRON DEFICIENCY ANEMIA THERAPY//New Day in Medicine 6(80)2025 369-373 https://newdayworldmedicine.com/en/new_day_medicine/6-80-2025

List of References

  1. World Health Organisation (2003): Adherence to long-term therapies, evidence for action. Geneva: http: // www.who.int2
  2. Simpson SH, Eurich DT, Majumdar SR, Padwal RS., Tsuyuki RT., Varney J, JohnsonJ A. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 2006;333:15-20
  3. Brookhart MA, Patrick AR, Dormuth C. et al. Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. Am J Epidemiol. 2007;166:348-54
  4. Ye X, Gross CR, Schommer J, Cline R, St. Peter WL. Association between copayment and adherence to statin teatment after coronary heart disease hospitalization; a longitudinal, retrospective, cohort study. Clin Ther 2007;29(12):2748-2757
  5. Struthers AD, Anderson G, MacFadyen RJ, et al. Nonadherence with ACE inhibitors is common and can be detected in clinical practice by routine serum ACE activity. Congest Heart Fail 2001 Jan-Feb;7(1):43-46
  6. Murray CJ, Lopez AD, Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997; 349:1436–1442.
  7. Eaddy M., Grogg A., Locklear J. Assessment of compliance with antipsychotic treatment and resource utilization in a Medicaid population. Clinical Therapeutics 2005; 27:263–272
  8. Valenstein M, Copeland LA, Blow FC.et al. Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Medical Care 2002;40: 630–639
  9. Ho PM., Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, Magid DJ. Effect of Medication Nonadherence on Hospitalization and Mortality among Patients with Diabetes Mellitus. Arch Intern Med. 2006;166:1836-1841е

    file

    download